Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
2016
Purpose
Recent evidence suggests that statin intolerance may be more common than reported in randomized trials. However, the statin-intolerant population is not well characterized. The goal of this report is to characterize the population enrolled in the phase 3 Goal Achievement after Utilizing an anti-PCSK9 antibody in Statin Intolerant Subjects Study (GAUSS-2; NCT 01763905).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
47
References
15
Citations
NaN
KQI